蒋学俊，男，1967年11月生，籍贯湖北。1998年毕业于同济医科大学，医学博士。教授、主任医师，博士生导师。主要从事介入心脏病学，研究方向为冠心病介入和生物材料应用，承担国家及省部级课题6项，发表论文百余篇，已培养博士生10人，硕士生20名，目前正在培养的博士生5名，硕士生5名。　

主要研究方向：

1. 介入心脏病学

2. 生物材料应用

教育履历：

1985-1991  同济医科大学临床医学系医学学士

1993-1998  同济医科大学附属同济医院 内科学医学博士

1998-2001  美国纽约州州立大学和宾西法尼亚州州立博士后

研究成果获奖：

湖北省科技进步三等奖一项

湖北省自然科学三等奖一项

湖北省自然科学论文奖一等奖

武汉市科技进步奖三等奖一项

论文代表作：

1.Carabin: Endogenous calcineurin inhibitor, a potential diagnostic and therapeutic target for cardiac hypertrophy in heart failure. Int J Cardiol, 2016, 212:57~58.

2.12-Month Coronary Angiography, Intravascular Ultrasound and Histology Evaluation of a Novel Fully Bioabsorbable Poly-L-Lactic Acid/Amorphous Calcium Phosphate Scaffolds in Porcine Coronary Arteries. J Biomed Nanotechnol, 2016, 12(4):743~752.

3.Histone methyltransferases: novel targets for tumor and developmental defects. Am J Transl Res, 2015, 7(11):2159~2175.

4.6-Month Follow-Up of a Novel Biodegradable Drug-Eluting Stent Composed of Poly-L-Lactic Acid and Amorphous Calcium Phosphate Nanoparticles in Porcine Coronary Artery. J Biomed Nanotechnol, 2015, 11(10):1819~1825.

5.Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease. J Biomed Nanotechnol, 2014, 10(7):1194~1204.

6.Improved biocompatibility of poly(lactic-co-glycolic acid) orv and poly-L-lactic  acid blended with nanoparticulate amorphous calcium phosphate in vascular stent applications. J Biomed Nanotechnol, 2014, 10(6):900~910.

7.The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel. Biomaterials, 2009, 30(25):4161~4167.

8.Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling. Eur J Heart Fail, 2009, 11(1):14~19.

9.Bone marrow stem cells implantation with alpha-cyclodextrin/MPEG -PCL-MPEG hydrogel improves cardiac function after myocardial infarction. Acta Biomater. 2009,5(8):2939-44.

10.Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction. J Biomed Mater Res A. J Biomed Mater Res A. 2009,10;90 (2):472-477.